Neonatal thrombocytopenia associated with gestational hypertension, preeclampsia and eclampsia: a case-control study


  • Sunil Kumar P. Department of Pediatrics, Adichunchanagiri Institute of Medical Science, B.G. Nagara, Karnataka, India
  • Haricharan K. R. Department of Pediatrics, Adichunchanagiri Institute of Medical Science, B.G. Nagara, Karnataka, India



Neonatal thrombocytopenia, Gestational hypertension, Eclampsia, Preeclampsia


Background: Gestational hypertension, preeclampsia and eclampsia syndrome is a multi-system disorder associated with adaptive changes in the fetal circulation and causes a marked imbalance in the haemostatic system of the mother and the neonate. These babies may have platelet changes and can lead to serious neonatal complication like sepsis and bleeding manifestations including intracranial hemorrhage. Therefore early platelet screening of these infants is recommended.

Methods: This is a prospective study conducted at Sri Adichunchanagiri Institute of Medical Sciences from January 2011 to January 2013. The case group comprised of 150 neonates born to mothers diagnosed either with gestational hypertension, preeclampsia and eclampsia while controls comprised of 150 apparently healthy newborns born to normotensive mothers without maternal complications, born during the same period. Cord blood was collected from these babies and platelet count was studied.

Results: Mothers with gestational hypertension, preeclampsia and eclampsia syndrome had a higher number of premature and small for gestational age babies. Platelet counts were significantly decreased in these mothers and babies compared to controls. The platelet count in the baby was affected by the severity of hypertension in the mother. At higher levels of maternal systolic and diastolic blood pressure the number of babies in the case group presenting with thrombocytopenia increased.

Conclusions: As these babies are more prone for development of thrombocytopenia during the early neonatal period, these babies should be closely monitored and managed in order to decrease the perinatal morbidity and mortality.


Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2005:110-21.

Steer P, Lupton M, Oteng-Ntim E. Hypertensive diseases in pregnancy. In: Rennie and Robertson’s Textbook of neonatology. 4th ed. Philadelphia: Churchill livingstone. 2008:179-81.

Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelets: a severe consequence of hypertension in pregnancy Obstet Gynecol. 1982;142:159-63.

Castle V, Andrew M, Kelton J, Girdon D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1996;108:749-55.

Murray NA, Roberts AG. Circulating Megakaryocytes and their Progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 1996;40:112-9.

Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr. 1980;97(5):791-4.

Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007;131(5):1308-14.

Weksler BB. Platelets and the inflammatory response. Clin Lab Med. 1983;3(4):667-76.

Raizada N, Lal A, Bhatia RC, Jain BK, Chander K, Goyal A. Neonatal thrombocytopenia due to pregnancy induced hypertension. Indian J Pediatr. 1996;63:226-8.

Scott JP and Montgomery RR. Platelet and Blood Vessel disorders. In: Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier Saunders. 2012;478:1714.

de Souza Rugolo LM, Bentlin MR, Petean Trindade CE. Preeclampsia: Effect on the fetus and newborn. Neo Reviews. 2011;12(4):e198-e206.

Kim HY, Sohn YS, Lim JH Kim EH, Kwon JY, Park YW, et al. Neonatal outcome after preterm delivery in HELLP syndrome. Yonsei Med J. 2006;47(3):393-8.

Procianoy RS, Silveira RC, Mussi-Pinhata MM, Souza Rugolo LM, Leone CR, de Andrade Lopes JM, et al. Brazilian network on neonatal research. Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia. J Pediatr. 2010;157(3):434-8.

Pritchard JA, Cunningham FG, Pritchard SA, Mason RA. How often does maternal preeclampsia incite thrombocytopenia in the fetus? Obstat Gynecol. 1987;69:292-5.

Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty sixth week of pregnancy. J Pediatr. 1982;100(2):265-71.

Bhat YR, Cherian CS. Neonatal thrombocytopenia associated with maternal pregnancy induced hypertension. Indian J Pediatr. 2008;75(6):571-3.

Fraser SH, Tudehope D. Neonatal neutropenia and thrombocytopenia following maternal hypertension. J Paediatr Child Health. 1996;32:31-4.

Sivakumar S, Bhat BV, Badhe BA. Effect of pregnancy induced hypertension on mothers and their babies. Indian J Pediatr. 2007;74(7):623-5.

Burrows RF, Andrew MD. Neonatal thrombocytopenia in hypertensive disorders of pregnancy. Obstat Gynecol. 1990;76:234-7.

Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelets, a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159-63.

Thiagarajah S, Bourgeois FJ, Harbert GM, Caudle MR. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol. 1984;150(1):1-7.






Original Research Articles